In this episode of Data Analytics Chat, we discuss the impact of AI on clinical research. Ben Gmeiner, Director of Medical Data Strategy and Science at Novartis, a global pharmaceutical organisation, joins us. We discuss AI's massive potential to revolutionise healthcare, enhance precision medicine, and improve clinical trials. Ben highlights the importance of integrating AI smoothly into existing workflows, ensuring data privacy, and overcoming regulatory challenges. We explore how...